Table 2.
Results for fully adherent patients and full sample
| Fully adherent (n = 18) | All patients (n = 21) | |
|---|---|---|
| Median baseline plasma viral load (copies/mL) | ||
| High ANS | 74,675 | 74,675 |
| Low ANS | 16,561 | 14,838 |
| Difference (high − low ANS) | P = 0.156 | P = 0.103 |
| Median follow-up plasma viral load (copies/ml) | ||
| High ANS | 44,776 | 44,776 |
| Low ANS | <400 | 488 |
| Difference (high − low ANS) | P = 0.013 | P = 0.004 |
| Correlation of change in viral load with ANS activity | r = 0.701 | r = 0.629 |
| P = 0.008 | P = 0.009 | |
| Median baseline CD4+ T cells/mm3 peripheral blood | ||
| High ANS | 602 | 611 |
| Low ANS | 396 | 421 |
| Difference (high − low ANS) | P = 0.877 | P = 0.993 |
| Median follow-up CD4+ T cells/mm3 peripheral blood | ||
| High ANS | 651 | 627 |
| Low ANS | 551 | 558 |
| Difference (high − low ANS) | P = 0.015 | P = 0.035 |
| Correlation of change in viral load with ANS activity | r = 0.701 | r = 0.629 |
| P = 0.008 | P = 0.009 |